glucose, (beta-d)-isomer has been researched along with Debility in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belohlávek, J; Bengtsson, O; Butt, JH; Chiang, CE; Dewan, P; Docherty, KF; Drożdż, J; Inzucchi, SE; Jhund, PS; Kitakaze, M; Kosiborod, MN; Køber, L; Langkilde, AM; Lindholm, D; Martinez, FA; McMurray, JJV; Merkely, B; Ponikowski, P; Sabatine, MS; Schou, M; Sjöstrand, M; Solomon, SD; Tereshchenko, S | 1 |
| Slomski, A | 1 |
| Bachus, E; Belohlávek, J; Butt, JH; Chiang, CE; Claggett, BL; de Boer, RA; Desai, AS; Drożdż, J; Hernandez, AF; Inzucchi, SE; Jhund, PS; Katova, T; Kitakaze, M; Kosiborod, MN; Lam, CSP; Lindholm, D; Maria Langkilde, A; Martinez, F; McMurray, JJV; Merkely, B; Petersson, M; Saraiva, JFK; Shah, SJ; Solomon, SD; Vaduganathan, M; Vardeny, O; Wilderäng, U | 1 |
| Butt, JH; McMurray, JJV; Solomon, SD | 1 |
2 trial(s) available for glucose, (beta-d)-isomer and Debility
| Article | Year |
|---|---|
Efficacy and Safety of Dapagliflozin According to Frailty in Heart Failure With Reduced Ejection Fraction : A Post Hoc Analysis of the DAPA-HF Trial.
Topics: Benzhydryl Compounds; Diabetes Mellitus, Type 2; Frailty; Glucosides; Heart Failure; Humans; Stroke Volume; Ventricular Dysfunction, Left; Ventricular Function, Left | 2022 |
Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER Trial.
Topics: Benzhydryl Compounds; Frailty; Glucosides; Heart Failure; Humans; Quality of Life; Stroke Volume | 2022 |
2 other study(ies) available for glucose, (beta-d)-isomer and Debility
| Article | Year |
|---|---|
Dapagliflozin Safe and Effective for Heart Failure With Frailty.
Topics: Benzhydryl Compounds; Cardiovascular Agents; Frailty; Glucosides; Heart Failure; Humans; Sodium-Glucose Transporter 2 Inhibitors; Stroke Volume; Treatment Outcome | 2022 |
Response by Butt et al to Letter Regarding Article, "Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER Trial".
Topics: Benzhydryl Compounds; Frailty; Glucosides; Heart Failure; Humans | 2023 |